Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement.
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement.
复制标题
DOI：
10.1111/j.1756-5391.2010.01086.x
复制
发表时间：
2010-08-01
影响因子：
--
通讯作者：
Moher, David
中科院分区：
文献类型：
--
作者：
MacPherson, Hugh;Altman, Douglas G;Moher, David
2001年和2002年，《针灸临床试验干预措施报告标准》（STRICTA）在五种期刊上发表。这些指南以供作者和期刊编辑使用的清单和解释的形式，旨在改善针灸试验的报告，特别是干预措施，从而促进其解释和复制。随后对《严格管制措施和管制措施法》的适用和影响进行的审查突出了《严格管制措施和管制措施法》的价值以及改进和修订的余地。为了管理修订过程，STRICTA集团、CONSORT集团和中国科克伦中心于2008年开展了合作。召集了一个有47名与会者的专家小组，就清单修订草案提供了电子反馈意见。在随后于弗赖堡举行的一次面对面会议上，一个由21名与会者组成的小组进一步修订了《打击跨国有组织犯罪特别措施》清单，并计划予以传播。新的STRICTA清单是CONSORT的正式扩展，包括6个项目和17个分项。这些指南规定了针灸原理、针刺细节、治疗方案、治疗的其他组成部分、从业者背景以及对照或比较干预措施的报告指南。此外，作为这一修订过程的一部分，对每个项目都作了详细说明，并提供了每个项目良好报告的实例。此外，将STRICTA中的“对照”一词替换为“临床”，以表明STRICTA适用于广泛的临床评价设计，包括非对照结局研究和病例报告。修订后的STRICTA与主要CONSORT声明和非药物治疗扩展声明一起，将提高针灸临床试验报告的质量。
The STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) were published in five journals in 2001 and 2002. These guidelines, in the form of a checklist and explanations for use by authors and journal editors, were designed to improve reporting of acupuncture trials, particularly the interventions, thereby facilitating their interpretation and replication. Subsequent reviews of the application and impact of STRICTA have highlighted the value of STRICTA as well as scope for improvements and revision. To manage the revision process a collaboration between the STRICTA Group, the CONSORT Group, and the Chinese Cochrane Centre was developed in 2008. An expert panel with 47 participants was convened that provided electronic feedback on a revised draft of the checklist. At a subsequent face-to-face meeting in Freiburg, a group of 21 participants further revised the STRICTA checklist and planned dissemination. The new STRICTA checklist, which is an official extension of CONSORT, includes six items and 17 sub-items. These set out reporting guidelines for the acupuncture rationale, the details of needling, the treatment regimen, other components of treatment, the practitioner background, and the control or comparator interventions. In addition, and as part of this revision process, the explanations for each item have been elaborated, and examples of good reporting for each item are provided. In addition, the word "controlled" in STRICTA is replaced by "clinical," to indicate that STRICTA is applicable to a broad range of clinical evaluation designs, including uncontrolled outcome studies and case reports. It is intended that the revised STRICTA, in conjunction with both the main CONSORT Statement and extension for nonpharmacologic treatment, will raise the quality of reporting of clinical trials of acupuncture.